27 related articles for article (PubMed ID: 28231675)
1. The Relationship between a New Biomarker of Vagal Neuroimmunomodulation and Survival in Two Fatal Cancers.
Gidron Y; De Couck M; Schallier D; De Greve J; Van Laethem JL; Maréchal R
J Immunol Res; 2018; 2018():4874193. PubMed ID: 29854838
[TBL] [Abstract][Full Text] [Related]
2. Tobacco-use Cessation Counseling Service Usage.
Nadpara PA; Madhavan SS; Tworek C
W V Med J; 2016; 112(5):66-71. PubMed ID: 29368489
[TBL] [Abstract][Full Text] [Related]
3. The presence of autoantibodies is associated with improved overall survival in lung cancer patients.
Jing K; Zhao H; Cai J; Chen L; Zheng P; Ouyang L; Li G; Wang R
Front Oncol; 2023; 13():1234847. PubMed ID: 37799460
[TBL] [Abstract][Full Text] [Related]
4. [Chemotherapy in the Elderly with Non-Small Cell Lung Cancer: A Non-Interventional, Prospective, Multicentric Observational Study].
Heigener DF; Hoeffken G; Wuerflein D; Feurer M; Rittmeyer A; Huber RM; Pietsch M; Ring A; Deppermann KM
Dtsch Med Wochenschr; 2017 Feb; 142(4):e21-e27. PubMed ID: 28235221
[No Abstract] [Full Text] [Related]
5. Clinical characteristics and prediction model of long-term survival of patients with stage III non-small cell lung cancer.
Zhang J; Liu D
Transl Cancer Res; 2021 Mar; 10(3):1439-1448. PubMed ID: 35116469
[TBL] [Abstract][Full Text] [Related]
6. Female gender is an independent prognostic factor in non-small-cell lung cancer: a meta-analysis.
Nakamura H; Ando K; Shinmyo T; Morita K; Mochizuki A; Kurimoto N; Tatsunami S
Ann Thorac Cardiovasc Surg; 2011; 17(5):469-80. PubMed ID: 21881356
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in older patients with advanced non-small cell lung cancer in China.
Su Q; Sun YP; Liu YH; Li Z; Yang HY; Sun ZG; Cao BW; Jia JH
Tumori; 2014; 100(1):69-74. PubMed ID: 24675494
[TBL] [Abstract][Full Text] [Related]
8. Sex-associated differences in non-small cell lung cancer in the new era: is gender an independent prognostic factor?
Hsu LH; Chu NM; Liu CC; Tsai SY; You DL; Ko JS; Lu MC; Feng AC
Lung Cancer; 2009 Nov; 66(2):262-7. PubMed ID: 19299032
[TBL] [Abstract][Full Text] [Related]
9. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
[TBL] [Abstract][Full Text] [Related]
10. Association between Charlson comorbidity index score and outcome in patients with stage IIIB-IV non-small cell lung cancer.
Zhao L; Leung LH; Wang J; Li H; Che J; Liu L; Yao X; Cao B
BMC Pulm Med; 2017 Aug; 17(1):112. PubMed ID: 28806935
[TBL] [Abstract][Full Text] [Related]
11. Is there a gender difference in non-small cell lung cancer survival?
Chatkin JM; Abreu CM; Fritscher CC; Wagner MB; Pinto JA
Gend Med; 2004 Aug; 1(1):41-7. PubMed ID: 16115582
[TBL] [Abstract][Full Text] [Related]
12. [Effect of gender on the prognosis of patients with non-small cell lung cancer].
Xu QP; He F; Liu ZQ; Xiong WM; Lin JB; Cai L
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Feb; 38(2):244-247. PubMed ID: 28231675
[No Abstract] [Full Text] [Related]
13. Prognostic value of ERCC1 mRNA expression in non-small cell lung cancer, breast cancer, and gastric cancer in patients from Southern China.
Deng Q; Yang H; Lin Y; Qiu Y; Gu X; He P; Zhao M; Wang H; Xu Y; Lin Y; Jiang J; He J; Zhou JX
Int J Clin Exp Pathol; 2014; 7(12):8312-21. PubMed ID: 25674197
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
